HROW logo

HROW Harrow Health, Inc.

NASDAQ Global Market · Drug Manufacturers - Specialty & Generic · Healthcare

$30.41
-1.72 (-5.35%)

Harrow Health, Inc. operates as a healthcare enterprise with a specialized focus on ophthalmic solutions. The company's portfolio includes ImprimisRx, a business dedicated to ophthalmology outsourcing and pharmaceutical compounding, as well as DEXYCU, a product utilized for managing post-operative inflammation. Beyond its direct offerings, Harrow Health maintains equity investments in several phar…

Market Cap: $1.14Bwww.harrow.com

Price

No data yet.

Social Signal Score

48
5d
—
30d
47
9 mentions
—
60d
48
11 mentions
—
90d
48
11 mentions
—
news: 11

Analyst Ratings

10 analysts
Buyconsensus
Strong Buy 0Buy 10Hold 0Sell 0Strong Sell 0
Avg price target$45+48.0%
Low $45Median $45High $45
Current Consensus

Revenue

$99.30M+1614.09%
$5.79M$36.96M$68.13M$99.30M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$0.06
$-1.01–$0.84
3 analysts
FY2026
$-0.36-705% YoY
$-0.50–$-0.16
5 analysts
FY2027
$1.48
$0.47–$2.28
5 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Mark L. Baum
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
373
Beta
0.24
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
2.09
www.harrow.com